2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosis

Lifespan Normative Data on Rates of Brain Volume Changes

(2019) M. Battaglini et al.   NEUROBIOLOGY OF AGING

Deep gray matter volume loss drives disability worsening in multiple sclerosis

(2018) Arman Eshaghi et al.   ANNALS OF NEUROLOGY

‘No evidence of disease activity’ - is it an appropriate surrogate in multiple sclerosis?

(2018) H. Hegen et al.   EUROPEAN JOURNAL OF NEUROLOGY

Establishing pathological cut-offs for lateral ventricular volume expansion rates

(2018) Michael G. Dwyer et al.   NeuroImage-Clinical

Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine

(2018) E. Ghione et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study

(2018) G. Pontillo et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Treatment of multiple sclerosis — success from bench to bedside

(2018) Mar Tintore et al.   Nature Reviews Neurology

Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies

(2017) E. Havrdova et al.   EUROPEAN JOURNAL OF NEUROLOGY

Pathological cut-offs of global and regional brain volume loss in multiple sclerosis

(2017) Tomas Uher et al.   Multiple Sclerosis Journal

Pathological cut-offs of global and regional brain volume loss in multiple sclerosis

(2017) Tomas Uher et al.   Multiple Sclerosis Journal

Cerebellar volume as imaging outcome in progressive multiple sclerosis

(2017) Matilde Inglese et al.   PLoS One

Gut microbiome analysis in neuromyelitis optica reveals overabundance ofClostridium perfringens

(2016) Bruce A. C. Cree et al.   ANNALS OF NEUROLOGY

Prediction models need appropriate internal, internal–external, and external validation

(2016) Ewout W. Steyerberg et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

B2 Cell-based assays of CAG repeat instability in the huntingtin (HTT) gene

(2016) Tom Massey et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Automated brain volumetrics in multiple sclerosis: a step closer to clinical application

(2016) C Wang et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients

(2016) Robert Zivadinov et al.   Multiple Sclerosis Journal

Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis

(2016) Ludwig Kappos et al.   Multiple Sclerosis Journal

A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients

(2016) Robert Zivadinov et al.   Multiple Sclerosis Journal

Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis

(2016) Ludwig Kappos et al.   Multiple Sclerosis Journal

Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis

(2015) A. Traboulsee et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process

(2015) Àlex Rovira et al.   Nature Reviews Neurology

Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort

(2015) Dalia L. Rotstein et al.   JAMA Neurology

Is it time to target no evident disease activity (NEDA) in multiple sclerosis?

(2015) Gavin Giovannoni et al.   Multiple Sclerosis and Related Disorders

New Multiple Sclerosis Phenotypic Classification

(2014) Fred D. Lublin   EUROPEAN NEUROLOGY

Third ventricular enlargement in early stages of multiple sclerosis is a predictor of motor and neuropsychological deficits: a cross-sectional study

(2013) Martin Müller et al.   BMJ Open

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Evaluating and reducing the impact of white matter lesions on brain volume measurements

(2011) Marco Battaglini et al.   HUMAN BRAIN MAPPING

Rate of ventricular enlargement in multiple sclerosis: a nine-year magnetic resonance imaging follow-up study

(2008) J. Martola et al.   ACTA RADIOLOGICA

Validation of linear cerebral atrophy markers in multiple sclerosis

(2007) H. Butzkueven et al.   JOURNAL OF CLINICAL NEUROSCIENCE